Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts

Stress

Volumn 16, Issue 1, 2013, Pages 114-121

  Flint, Melanie S ^a,b   Baum, Andrew ^c   Episcopo, Britteny ^b   Knickelbein, Kelly Z ^b   Liegey Dougall, Angela J ^c   Chambers, William H ^a,b   Jenkins, Frank J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Catecholamines; Comet assay; DNA damage; Epinephrine; Norepinephrine; Propranolol

Indexed keywords

ADRENALIN; DNA; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL STRAIN 3T3; CELL TRANSFORMATION; CHRONIC STRESS; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FIBROBLAST; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARCINOGENICITY TESTS; CELL TRANSFORMATION, NEOPLASTIC; COMET ASSAY; DISEASE PROGRESSION; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; FEMALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NIH 3T3 CELLS; NOREPINEPHRINE; PROPRANOLOL; STRESS, PSYCHOLOGICAL;

EID: 84870848163     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2012.686075     Document Type: Article

References (38)

1. Barnes PJ. 1995. Beta-adrenergic receptors and their regulation.Am J Respir Crit Care Med 152:838-860.
2. Ben-Eliyahu S. 2003. The promotion of tumor metastasis by surgery and stress: Immunological basis and implications for psychoneuroimmunology. Brain Behav Immun 17(Suppl. 1): S27-S36.
3. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. 1999. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 80: 880-888.
4. Caldecott KW. 2008. Single-strand break repair and genetic disease. Nat Rev Genet 9:619-631.
5. Collins AR. 2004. The comet assay for DNA damage and repair: Principles, applications, and limitations. Mol Biotechnol 26: 249-261.
6. Daly CJ, McGrath JC. 2011. Previously unsuspected widespread cellular and tissue distribution of beta-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci 32:219-226.
7. Flint MS, Baum A, Chambers WH, Jenkins FJ. 2007. Induction of DNA damage, alteration of DNA repair and transcriptional activation by stress hormones. Psychoneuroendocrinology 32: 470-479.
8. Fox BH. 1978. Premorbid psychological factors as related to cancer incidence. J Behav Med 1:45-133.
9. Fox BH. 1984. Remote life-style causes of cancer. Cancer Detect Prev 7:21-29.
10. Fox BH, Goldsmith JR. 1976. Behavioral issues in prevention of cancer. Prev Med 5:106-121.
11. Garssen B, Goodkin K. 1999. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res 85:51-61.
12. Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, Meiboom H, Ben-Eliyahu S. 2010. Improving survival rates in two models of spontaneous post-operative metastasis in mice by combined administration of a b-adrenergic antagonist and a cyclooxygenasae-2 inhibitor. J Immunol 184:2449-2457.
13. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
14. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, Shenoy SK, Gregory SG, Ahn S, Duckett DR, Lefkowitz RJ. 2011. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477:349-353.
15. Hasegawa H, Saiki I. 2002. Psychosocial stress augments tumor development through beta-adrenergic activation in mice. Jpn J Cancer Res 93:729-735.
16. Jiricny J. 2006. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 7:335-346.
17. Landen CN, Jr, Lin YG, Armaiz Pena GN, Das PD, Arevalo JM, Kamat AA, Han LY, Jennings NB, Spannuth WA, Thaker PH, Lutgendorf SK, Savary CA, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. 2007. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67:10389-10396.
18. Li J, Yan B, Huo Z, Liu Y, Xu J, Sun Y, Liu Y, Liang D, Peng L, Zhang Y, Zhou ZN, Shi J, Cui J, Chen YH. 2010. Beta2-but not beta1-adrenoceptor activation modulates intracellular oxygen availability. J Physiol 588:2987-2998.
19. Lillberg K, Verkasalo PK, Kaprio J, Teppo L, Helenius H, Koskenvuo M. 2003. Stressful life events and risk of breast cancer in 10,808 women: A cohort study. Am J Epidemiol 157: 415-423.
20. Lindahl T, Barnes DE. 2000. Repair of endogenous DNA damage. Cold Spring Harbor Symp Quant Biol 65:127-133.
21. Lutgendorf SK, DeGeest K, Dahmoush L, Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L, Krueger G, Clevenger L, Lubaroff DM, Sood AK, Cole SW. 2011. Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behav Immun 25:250-255.
22. Masur K, Niggemann B, Zanker KS, Entschladen F. 2001. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61:2866-2869.
23. Michael YL, Carlson NE, Chlebowski RT, Aickin M, Weihs KL, Ockene JK, Bowen DJ, Ritenbaugh C. 2009. Influence of stressors on breast cancer incidence in the Women's Health Initiative. Health Psychol 28:137-146.
24. Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE, Sanguino AM, Lopez-Berestein G, Cole SW, Sood AK. 2007. Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism. J Biol Chem 282:29919-29926.
25. Palm D, Lang K, Niggemann B, Drell TL, IV, Masur K, Zaenker KS, Entschladen F. 2006. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 118: 2744-2749.
26. Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Diz PG, Gandara Rey JM, Garcia-Garcia A. 2010. Beta-adrenergic receptors in cancer: Therapeutic implications. Oncol Res 19: 45-54.
27. Powe DG, Entschladen F. 2011. Targeted therapies: Using betablockers to inhibit breast cancer progression. Nat Rev Clin Oncol 8:511-512.
28. Reiche EM, Nunes SO, Morimoto HK. 2004. Stress, depression, the immune system, and cancer. Lancet Oncol 5:617-625.
29. Ross K. 2008. Mapping pathways from stress to cancer progression. J Natl Cancer Inst 100:914-915, 917.
30. Sheppard JR. 1977. Catecholamine hormone receptor differences identified on 3T3 and simian virus-transformed 3T3 cells. Proc Natl Acad Sci USA 74:1091-1094.
31. Sheppard JR, Gormus R, Moldow CF. 1977. Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes. Nature 269:693-695.
32. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JMG, Morizono K, Karanikolas BDW, Wu L, Sood AK, Cole SW. 2010. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 70:7042-4052.
33. Slotkin TA, Zhang J, Dancel R, Garcia SJ, Willis C, Seidler FJ. 2000. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 60:153-166.
34. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. 2006. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939-944.
35. Tilan J, Kitlinska J. 2010. Sympathetic neurotransmitters and tumor angiogenesis-link between stress and cancer progression. J Oncol 2010:539706.
36. West SC. 2003. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 4:435-445.
37. Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R. 2006. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66:10357-10364.
38. Yang EV, Donovan EL, Benson DM, Glaser R. 2008. VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun 22:318-323.